Fairmount Funds Management LLC
- SEC CIK
- 0001802528
- Latest filing
- Aug 14, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 20
- 0 vs. Q3 2021
- Portfolio value
- $303.3M
- +$28.3M (+10.3%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ZGNXZogenix, Inc. | COM NEW | 2,502,259 | $40.7M | 13.4% | +560,000+28.8% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 1,313,607 | $35.8M | 11.8% | 00.0% | Unchanged | History |
| ENTAEnanta Pharmaceuticals Inc | COM | 387,400 | $29.0M | 9.6% | +70,448+22.2% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 78,644 | $27.5M | 9.1% | +20,000+34.1% | Added | History |
| GBTGlobal Blood Therapeutics, Inc. | COM | 743,000 | $21.7M | 7.2% | +493,000+197.2% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 944,092 | $18.7M | 6.2% | 00.0% | Unchanged | History |
| NUVLNuvalent, Inc. | COM | 914,614 | $17.4M | 5.7% | 00.0% | Unchanged | History |
| KROSKeros Therapeutics, Inc. | COM | 292,833 | $17.1M | 5.6% | +143,500+96.1% | Added | History |
| COGTCogent Biosciences, Inc. | COM | 1,558,975 | $13.4M | 4.4% | 00.0% | Unchanged | History |
| TILInstil Bio, Inc. | COM | 673,905 | $11.5M | 3.8% | 00.0% | Unchanged | History |
| ACADAcadia Pharmaceuticals Inc | COM | 416,817 | $9.73M | 3.2% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 645,349 | $9.08M | 3.0% | +146,309+29.3% | Added | History |
| PNTPOINT Biopharma Global Inc. | COM | 1,519,382 | $8.51M | 2.8% | +419,893+38.2% | Added | History |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 2,498,237 | $8.42M | 2.8% | −10,000−0.4% | Reduced | History |
| BHVNBiohaven Ltd. | COM | 55,647 | $7.67M | 2.5% | +55,647 | New | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 389,588 | $7.44M | 2.5% | 00.0% | Unchanged | History |
| AXSMAxsome Therapeutics, Inc. | COM | 187,598 | $7.09M | 2.3% | 00.0% | Unchanged | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 926,602 | $6.23M | 2.1% | 00.0% | Unchanged | History |
| ATXSAstria Therapeutics, Inc. | COM | 911,736 | $4.91M | 1.6% | 00.0% | Unchanged | History |
| ALLKAllakos Inc. | COM | 147,189 | $1.44M | 0.5% | −28,173−16.1% | Reduced | History |
Sold out since Q3 2021 (1)
Positions held at the end of Q3 2021 that are gone from this filing.
| Security | Class | Shares in Q3 2021 | Value in Q3 2021 | % of portfolio in Q3 2021 | History |
|---|---|---|---|---|---|
| Trillium Therapeutics Inc.89620X506 | COM NEW | 886,281 | $15.6M | 5.7% | – |